Salkind Gene 13D/13G Filings for Upexi, Inc. (UPXI)

Salkind Gene 13D and 13G filings for Upexi, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-03-10
4:36 pm
Purchase		 2022-12-31 13G Upexi, Inc.
UPXI		 Salkind Gene 122,369
13.560%		 2,552increase
(+2.13%)		 Filing
2022-02-14
4:08 pm
Purchase		 2021-12-31 13G Upexi, Inc.
UPXI		 Salkind Gene 119,817
14.600%		 119,817increase
(New Position)		 Filing